Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer
- 12 June 2007
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (24) , 10170-10174
- https://doi.org/10.1073/pnas.0703867104
Abstract
Bacterial infection occasionally has a marked therapeutic effect on malignancies, as noted as early as the 19th century. Recently, there have been attempts to develop cancer treatment by using tumor-targeting bacteria. These treatments were developed to deliver therapeutic molecules specifically to tumors. Researchers used anaerobic microorganisms that preferentially grew in necrotic tumor areas. However, the resulting tumor killing was, at best, limited. We have developed a far more effective bacterial cancer therapy by targeting viable tumor tissue by using Salmonella typhimurium leu-arg auxotrophs. Although these bacteria grow in viable as well as necrotic areas of tumors, the nutritional auxo trophy severely restricts growth in normal tissue. In the current study, we measured the antitumor efficacy of the S. typhimurium A1-R mutant, which is auxotrophic for leu-arg and has increased antitumor virulence selected by tumor passage. A1-R was used to treat metastatic PC-3 human prostate tumors that had been orthotopically implanted in nude mice. GFP was used to image tumor and metastatic growth. Of the 10 mice with the PC-3 tumors that were injected weekly with S. typhimurium A1-R, 7 were alive and well at the time the last untreated mouse died. Four A1-R-treated mice remain alive and well 6 months after implantation. Ten additional nontumor-bearing mice were injected weekly to determine the toxicity of S. typhimurium A1-R. No toxic effects were observed. The approach described here, where bacterial monotherapy effectively treats metastatic prostate tumors, is a significant improvement over previous bacterial tumor-therapy strategies that require combination with toxic chemotherapy.Keywords
This publication has 35 references indexed in Scilit:
- A Bacterial Protein Enhances the Release and Efficacy of Liposomal Cancer DrugsScience, 2006
- Development of a flexible and potent hypoxia-inducible promoter for tumor-targeted gene expression in attenuated salmonellaCancer Biology & Therapy, 2006
- Targeted Therapy with aSalmonella TyphimuriumLeucine-Arginine Auxotroph Cures Orthotopic Human Breast Tumors in Nude MiceCancer Research, 2006
- Real‐time whole‐body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent proteinThe Prostate, 2004
- Cellular Dynamics Visualized in Live Cells in Vitro and in Vivo by Differential Dual-Color Nuclear-Cytoplasmic Fluorescent-Protein ExpressionCancer Research, 2004
- Biodistribution and Genetic Stability of the Novel Antitumor Agent VNP20009, a Genetically Modified Strain ofSalmonella typhimuriumThe Journal of Infectious Diseases, 2000
- Use of preferentially replicating bacteria for the treatment of cancerJournal of Clinical Investigation, 2000
- Bifidobacterium longum as a delivery system for cancer gene therapy: Selective localization and growth in hypoxic tumorsCancer Gene Therapy, 2000
- Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironmentGene Therapy, 1997
- Clostridial oncolysis in manEuropean Journal of Cancer (1965), 1967